| The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease. | |
| | |
MedLine Citation:
|
PMID: 22971163 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Purpose: To study the effectiveness of mycophenolate mofetil (MMF) as first-line therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada (VKH) disease. The outcomes in this group were compared with those of another group of patients with VKH disease who were treated with corticosteroid monotherapy or with delayed addition of immunomodulatory therapy. Methods: This prospective study included 19 patients (38 eyes) diagnosed with acute uveitis associated with VKH disease. Results: The mean follow-up period was 27.0 ± 11.1 months (range 16-54 months). Corticosteroid-sparing effect was achieved in all patients. The mean interval between starting treatment and tapering prednisone to 10 mg or less daily was 5.1 ± 1.2 months (range 3-7 months). Ten (53%) patients discontinued treatment without relapse of inflammation. The mean time observed of treatment was 17.3 ± 11.9 months (range 3-41.5 months). Visual acuity of 20/20 was achieved by 38% of the eyes in the corticosteroid group and by 74% in the corticosteroid + MMF group (p < 0.001). Recurrent inflammation of ≥3 times was reduced significantly (p = 0.0383) in the corticosteroid + MMF group (3%) as compared to corticosteroid group (18%). Development of all complications was significantly higher in the corticosteroid group (43%) compared with the corticosteroid + MMF group (8%) (p < 0.001). None of the eyes in the corticosteroid + MMF group developed 'sunset glow fundus'. Conclusions: Addition of MMF as first-line therapy to corticosteroids in patients with acute uveitis associated with VKH disease leads to significant reduction in recurrences of uveitis and development of late complications and significantly improves visual outcome. |
| | |
Authors:
|
Ahmed M Abu El-Asrar; Suhail Hemachandran; Hani S Al-Mezaine; Dustan Kangave; Abdulrahman M Al-Muammar |
Related Documents
:
|
22935243 - Effects of computer-assisted oral anticoagulant therapy. 23253473 - Is there still a role for empiric first line triple therapy using proton pump inhibitor... 22890513 - Outcome of severe steroid-dependent nephrotic syndrome treated with mycophenolate mofetil. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-9-12 |
Journal Detail:
|
Title: Acta ophthalmologica Volume: - ISSN: 1755-3768 ISO Abbreviation: Acta Ophthalmol Publication Date: 2012 Sep |
Date Detail:
|
Created Date: 2012-9-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101468102 Medline TA: Acta Ophthalmol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2012 The Authors. Acta Ophthalmologica © 2012 Acta Ophthalmologica Scandinavica Foundation. |
Affiliation:
|
Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Insulin receptor and glucose transporters mRNA expression throughout the menstrual cycle in human en...
Next Document: Modelling salmon lice, Lepeophtheirus salmonis, reproduction on farmed Atlantic salmon, Salmo salar ...